These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 18977094

  • 1. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
    Mehta MP, Shapiro WR, Phan SC, Gervais R, Carrie C, Chabot P, Patchell RA, Glantz MJ, Recht L, Langer C, Sur RK, Roa WH, Mahe MA, Fortin A, Nieder C, Meyers CA, Smith JA, Miller RA, Renschler MF.
    Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1069-76. PubMed ID: 18977094
    [Abstract] [Full Text] [Related]

  • 2. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.
    Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, Souhami L, Bezjak A, Leibenhaut M, Komaki R, Schultz C, Timmerman R, Curran W, Smith J, Phan SC, Miller RA, Renschler MF.
    J Clin Oncol; 2003 Jul 01; 21(13):2529-36. PubMed ID: 12829672
    [Abstract] [Full Text] [Related]

  • 3. Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study.
    Lee DH, Han JY, Kim HT, Yoon SJ, Pyo HR, Cho KH, Shin SH, Yoo H, Lee SH, Lee JS.
    Cancer; 2008 Jul 01; 113(1):143-9. PubMed ID: 18459180
    [Abstract] [Full Text] [Related]

  • 4. Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.
    Minniti G, Salvati M, Muni R, Lanzetta G, Osti MF, Clarke E, Costa A, Bozzao A, Trasimeni G, Enrici RM.
    Anticancer Res; 2010 Jul 01; 30(7):3055-61. PubMed ID: 20683055
    [Abstract] [Full Text] [Related]

  • 5. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial.
    Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, Kunkler I, Caudrelier JM, Eisenberg PD, Meerwaldt J, Siemers R, Carrie C, Gaspar LE, Curran W, Phan SC, Miller RA, Renschler MF.
    J Clin Oncol; 2004 Jan 01; 22(1):157-65. PubMed ID: 14701778
    [Abstract] [Full Text] [Related]

  • 6. [Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
    Yue X, Zang QC.
    Ai Zheng; 2004 Dec 01; 23(12):1671-6. PubMed ID: 15601558
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Whole brain irradiation for non-small-cell lung cancer with brain metastasis].
    Shi AH, Zhu GY, Yu R, Ma HM, Liu CQ, Su X, Sun Y, Cai Y, Xu XN, Zhang SW, Xu B.
    Zhonghua Zhong Liu Za Zhi; 2007 Jul 01; 29(7):545-8. PubMed ID: 18069640
    [Abstract] [Full Text] [Related]

  • 10. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.
    Suh JH, Stea B, Nabid A, Kresl JJ, Fortin A, Mercier JP, Senzer N, Chang EL, Boyd AP, Cagnoni PJ, Shaw E.
    J Clin Oncol; 2006 Jan 01; 24(1):106-14. PubMed ID: 16314619
    [Abstract] [Full Text] [Related]

  • 11. A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
    Knisely JP, Berkey B, Chakravarti A, Yung AW, Curran WJ, Robins HI, Movsas B, Brachman DG, Henderson RH, Mehta MP.
    Int J Radiat Oncol Biol Phys; 2008 May 01; 71(1):79-86. PubMed ID: 18164847
    [Abstract] [Full Text] [Related]

  • 12. A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung.
    Guerrieri M, Wong K, Ryan G, Millward M, Quong G, Ball DL.
    Lung Cancer; 2004 Oct 01; 46(1):107-11. PubMed ID: 15364138
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are needed.
    Brown PD, Asher AL, Farace E.
    Int J Radiat Oncol Biol Phys; 2008 Apr 01; 70(5):1305-9. PubMed ID: 18234426
    [Abstract] [Full Text] [Related]

  • 14. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.
    Rades D, Schild SE, Lohynska R, Veninga T, Stalpers LJ, Dunst J.
    Cancer; 2007 Sep 01; 110(5):1077-82. PubMed ID: 17614294
    [Abstract] [Full Text] [Related]

  • 15. Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?
    Rades D, Heisterkamp C, Schild SE.
    Int J Radiat Oncol Biol Phys; 2010 Oct 01; 78(2):398-403. PubMed ID: 20488627
    [Abstract] [Full Text] [Related]

  • 16. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
    Corn BW, Moughan J, Knisely JP, Fox SW, Chakravarti A, Yung WK, Curran WJ, Robins HI, Brachman DG, Henderson RH, Mehta MP, Movsas B.
    Int J Radiat Oncol Biol Phys; 2008 May 01; 71(1):71-8. PubMed ID: 18164829
    [Abstract] [Full Text] [Related]

  • 17. Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme.
    Ford JM, Seiferheld W, Alger JR, Wu G, Endicott TJ, Mehta M, Curran W, Phan SC.
    Int J Radiat Oncol Biol Phys; 2007 Nov 01; 69(3):831-8. PubMed ID: 17560737
    [Abstract] [Full Text] [Related]

  • 18. Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology.
    Moscetti L, Nelli F, Felici A, Rinaldi M, De Santis S, D'Auria G, Mansueto G, Tonini G, Sperduti I, Pollera FC.
    Cancer; 2007 Jan 15; 109(2):274-81. PubMed ID: 17154161
    [Abstract] [Full Text] [Related]

  • 19. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D, Bohlen G, Pluemer A, Veninga T, Hanssens P, Dunst J, Schild SE.
    Cancer; 2007 Jun 15; 109(12):2515-21. PubMed ID: 17487853
    [Abstract] [Full Text] [Related]

  • 20. Phase I study of concurrent whole brain radiotherapy and erlotinib for multiple brain metastases from non-small-cell lung cancer.
    Lind JS, Lagerwaard FJ, Smit EF, Senan S.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1391-6. PubMed ID: 19289264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.